Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

MEDICAL DEVICE MANUFACTURERS ASSOCIATION

Filed by MEDICAL DEVICE MANUFACTURERS ASSOCIATION.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 17, 2026
Income
Not reported
Expenses
$320,000.00
Filing UUID
e5e6e1db-164f-47d5-b47a-8be2228d5bf9
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)

BUD · Budget/Appropriations

Issues related to appropriations and user fee funding for the Food and Drug Administration

SMB · Small Business

Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program

CPT · Copyright/Patent/Trademark

Issues relating to the the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) (H.R. 3152) and Patent Eligibility Restoration Act (PERA) (S. 1546) patent legislation

Literal federal measure citations: H.R. 3152, S. 1546

HCR · Health Issues

Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act Issues related to competitive bidding Issues related to the National Defense Authorization Act (NDAA)

Literal federal measure citations: HR 3723, HR 5662, S 2907

MMM · Medicare/Medicaid

Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare

Literal federal measure citations: H.R. 5343, S.1717

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.